MiR-371 promotes proliferation and metastasis in hepatocellular carcinoma by targeting PTEN
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Hepatocellular carcinoma (HCC) is the leading cause of cancer-related mortality worldwide. MiR-371 has recently emerged as an important regulator in tumorigenesis, and may serve as a biomarker for malignant tumors. We transfected miR-371 or its inhibitor in two human HCC cell lines, then used 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, soft agar colony formation, and transwell migration assays to evaluate the effects on cell proliferation, migration, and invasion. We found that miR-371 was positively correlated with HCC metastasis and poor prognosis in the inflicted patients, and the high expression of miR-371 was promoted, whereas a low level of miR-371 depressed cell proliferation and invasion. We found PTEN to be a direct target of miR-371. The overexpression or knockdown of PTEN exhibited the opposite effects from those of miR-371 on cell proliferation and migration. Our study demonstrates that miR-371 promotes proliferation and metastasis in HCC by targeting PTEN.
Abstract
Hepatocellular carcinoma (HCC) is the leading cause of cancer-related mortality worldwide. MiR-371 has recently emerged as an important regulator in tumorigenesis, and may serve as a biomarker for malignant tumors. We transfected miR-371 or its inhibitor in two human HCC cell lines, then used 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, soft agar colony formation, and transwell migration assays to evaluate the effects on cell proliferation, migration, and invasion. We found that miR-371 was positively correlated with HCC metastasis and poor prognosis in the inflicted patients, and the high expression of miR-371 was promoted, whereas a low level of miR-371 depressed cell proliferation and invasion. We found PTEN to be a direct target of miR-371. The overexpression or knockdown of PTEN exhibited the opposite effects from those of miR-371 on cell proliferation and migration. Our study demonstrates that miR-371 promotes proliferation and metastasis in HCC by targeting PTEN.
참고문헌 (23)
- Llovet JM, "Hepatocellular carcinoma", Lancet, 362, pp.1907~1917 (2003)
- Bandiera S, "miR-122-A key factor and therapeutic target in liver disease", J Hepatol, 62, pp.448~457 (2015)
- Wiemer EAC, "The role of microRNAs in cancer : No small matter", Eur J Cancer, 43, pp.1529~1544 (2007)
- Negrini M, "microRNA involvement in hepatocellular carcinoma", Anticancer Agents Med Chem, 11, pp.500~521 (2011)
- Ghasemi M, "Upregulation of miR-371-373cluster, a human embryonic stem cell specific microRNA cluster, in esophageal squamous cell carcinoma", J Cancer Res Ther, 14, pp.S132~S137 (2018)[DOI]
- Murray MJ, "Identification of microRNAs From the miR-371~373 and miR-302 clusters as potential serum biomarkers of malignant germ cell tumors", Am J Clin Pathol, 135, pp.119~125 (2011)
- Belge G, "Serum levels of microRNAs miR-371-3: a novel class of serum biomarkers for testicular germ cell tumors?", Eur Urol, 61, pp.1068~1069 (2012)
- Cairo S, "Stem cell-like micro-RNA signature driven by Myc in aggressive liver cancer", Proc Natl Acad Sci U S A, 107, pp.20471~20476 (2010)
- Stepanenko AA, "Pitfalls of the MTT assay : Direct and off-target effects of inhibitors can result in over", underestimation of cell viability, 2015, pp.574, 193~203
- Borowicz S, "The soft agar colony formation assay", J Vis Exp, pp.e51998~ (2014)
- Horibata S, "Utilization of the soft agar colony formation assay to identify inhibitors of tumorigenicity in breast cancer cells", J Vis Exp, pp.e52727~ (2015)
- Fu X, "MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K", Akt pathway, 2017, pp.108, 620~631
- Agarwal V, "Predicting effective microRNA target sites in mammalian mRNAs", Elife, 4, pp.e05005~ (2015)
- Winter J, "Many roads to maturity : microRNA biogenesis pathways and their regulation", Nat Cell Biol, 11, pp.228~234 (2009)
- Zhang BG, "microRNA-21 promotes tumor proliferation and invasion in gastric cancer by targeting PTEN", Oncol Rep, 27, pp.1019~1026 (2012)
- Zhang C-z, "MicroRNA-221and microRNA-222 regulate gastric carcinoma cell proliferation and radioresistance by targeting PTEN", BMC Cancer, 10, pp.367~ (2010)
- Yang T-S, "MiR-214 regulate gastric cancer cell proliferation, migration and invasion by targeting PTEN", Cancer Cell International, 13, pp.68~ (2013)
- Shi W, "MicroRNA-301Mediates Proliferation and Invasion in Human Breast Cancer", Cancer Res, 71, pp.2926~2937 (2011)
- Mack GS, "MicroRNA gets down to business", Nat Biotechnol, 25, pp.631~638 (2007)
- Valastyan S, "Tumor metastasis : molecular insights and evolving paradigms", Cell, 147, pp.275~292 (2011)
- Fan SJ, "Role of NF-kappa B signaling in hepatocyte growth factor scatter factormediated cell protection", Oncogene, 24, pp.1749~1766 (2005)
- Budhu A, "Integrated metabolite and gene expression profiles identify lipid biomarkers associated with progression of hepatocellular carcinoma and patient outcomes", Gastroenterology, 144, pp.1066~1075 (2013)[DOI]
- Budhu A, "Identification of metastasis-related microRNAs in hepatocellular carcinoma", Hepatology, 47, pp.897~907 (2008)